vs
Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $49.9M, roughly 1.4× MARAVAI LIFESCIENCES HOLDINGS, INC.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -71.6%, a 73.6% gap on every dollar of revenue. On growth, RE/MAX Holdings, Inc. posted the faster year-over-year revenue change (-1.8% vs -11.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-24.9M). Over the past eight quarters, RE/MAX Holdings, Inc.'s revenue compounded faster (-4.7% CAGR vs -11.9%).
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
MRVI vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.9M | $71.1M |
| Net Profit | $-35.7M | $1.4M |
| Gross Margin | 25.8% | — |
| Operating Margin | -117.9% | 13.1% |
| Net Margin | -71.6% | 2.0% |
| Revenue YoY | -11.8% | -1.8% |
| Net Profit YoY | -37.7% | -75.2% |
| EPS (diluted) | $-0.24 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.9M | $71.1M | ||
| Q3 25 | $41.6M | $73.2M | ||
| Q2 25 | $47.4M | $72.8M | ||
| Q1 25 | $46.9M | $74.5M | ||
| Q4 24 | $56.6M | $72.5M | ||
| Q3 24 | $69.0M | $78.5M | ||
| Q2 24 | $69.4M | $78.5M | ||
| Q1 24 | $64.2M | $78.3M |
| Q4 25 | $-35.7M | $1.4M | ||
| Q3 25 | $-25.6M | $4.0M | ||
| Q2 25 | $-39.6M | $4.7M | ||
| Q1 25 | $-29.9M | $-2.0M | ||
| Q4 24 | $-25.9M | $5.8M | ||
| Q3 24 | $-97.1M | $966.0K | ||
| Q2 24 | $-9.8M | $3.7M | ||
| Q1 24 | $-12.1M | $-3.4M |
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
| Q4 25 | -117.9% | 13.1% | ||
| Q3 25 | -98.6% | 25.0% | ||
| Q2 25 | -139.8% | 19.3% | ||
| Q1 25 | -104.9% | 7.2% | ||
| Q4 24 | -66.7% | 5.9% | ||
| Q3 24 | -239.9% | 19.4% | ||
| Q2 24 | -19.4% | 20.6% | ||
| Q1 24 | -29.4% | 5.8% |
| Q4 25 | -71.6% | 2.0% | ||
| Q3 25 | -61.4% | 5.4% | ||
| Q2 25 | -83.5% | 6.4% | ||
| Q1 25 | -63.9% | -2.6% | ||
| Q4 24 | -45.8% | 8.0% | ||
| Q3 24 | -140.6% | 1.2% | ||
| Q2 24 | -14.1% | 4.7% | ||
| Q1 24 | -18.8% | -4.3% |
| Q4 25 | $-0.24 | — | ||
| Q3 25 | $-0.18 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.68 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.9M | $118.7M |
| Total DebtLower is stronger | $291.8M | $432.2M |
| Stockholders' EquityBook value | $212.4M | $452.4M |
| Total Assets | $770.6M | $582.5M |
| Debt / EquityLower = less leverage | 1.37× | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $216.9M | $118.7M | ||
| Q3 25 | $243.6M | $107.5M | ||
| Q2 25 | $269.9M | $94.3M | ||
| Q1 25 | $285.1M | $89.1M | ||
| Q4 24 | $322.4M | $96.6M | ||
| Q3 24 | $578.2M | $83.8M | ||
| Q2 24 | $573.2M | $66.1M | ||
| Q1 24 | $561.7M | $82.1M |
| Q4 25 | $291.8M | $432.2M | ||
| Q3 25 | $292.8M | $433.3M | ||
| Q2 25 | $293.9M | $434.4M | ||
| Q1 25 | $294.9M | $435.3M | ||
| Q4 24 | $295.9M | $436.2M | ||
| Q3 24 | $521.7M | $437.2M | ||
| Q2 24 | $522.5M | $438.1M | ||
| Q1 24 | $523.3M | $439.0M |
| Q4 25 | $212.4M | $452.4M | ||
| Q3 25 | $245.4M | $448.1M | ||
| Q2 25 | $265.9M | $442.4M | ||
| Q1 25 | $300.6M | $433.5M | ||
| Q4 24 | $325.3M | $429.5M | ||
| Q3 24 | $344.9M | $423.1M | ||
| Q2 24 | $434.7M | $418.4M | ||
| Q1 24 | $410.7M | $412.0M |
| Q4 25 | $770.6M | $582.5M | ||
| Q3 25 | $849.2M | $582.2M | ||
| Q2 25 | $897.0M | $574.8M | ||
| Q1 25 | $959.8M | $571.4M | ||
| Q4 24 | $1.0B | $581.6M | ||
| Q3 24 | $1.3B | $578.6M | ||
| Q2 24 | $1.4B | $571.4M | ||
| Q1 24 | $1.4B | $566.7M |
| Q4 25 | 1.37× | 0.96× | ||
| Q3 25 | 1.19× | 0.97× | ||
| Q2 25 | 1.11× | 0.98× | ||
| Q1 25 | 0.98× | 1.00× | ||
| Q4 24 | 0.91× | 1.02× | ||
| Q3 24 | 1.51× | 1.03× | ||
| Q2 24 | 1.20× | 1.05× | ||
| Q1 24 | 1.27× | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.8M | $40.9M |
| Free Cash FlowOCF − Capex | $-24.9M | $33.5M |
| FCF MarginFCF / Revenue | -49.9% | 47.1% |
| Capex IntensityCapex / Revenue | 4.2% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-70.7M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.8M | $40.9M | ||
| Q3 25 | $-15.2M | $17.7M | ||
| Q2 25 | $-10.3M | $4.6M | ||
| Q1 25 | $-9.4M | $5.7M | ||
| Q4 24 | $-14.6M | $59.7M | ||
| Q3 24 | $13.1M | $17.6M | ||
| Q2 24 | $17.4M | $15.9M | ||
| Q1 24 | $-8.5M | $9.4M |
| Q4 25 | $-24.9M | $33.5M | ||
| Q3 25 | $-18.1M | $16.4M | ||
| Q2 25 | $-13.1M | $2.9M | ||
| Q1 25 | $-14.6M | $4.0M | ||
| Q4 24 | $-20.5M | $53.0M | ||
| Q3 24 | $4.5M | $16.3M | ||
| Q2 24 | $7.9M | $14.0M | ||
| Q1 24 | $-14.1M | $6.8M |
| Q4 25 | -49.9% | 47.1% | ||
| Q3 25 | -43.4% | 22.4% | ||
| Q2 25 | -27.7% | 4.0% | ||
| Q1 25 | -31.2% | 5.3% | ||
| Q4 24 | -36.2% | 73.2% | ||
| Q3 24 | 6.6% | 20.8% | ||
| Q2 24 | 11.4% | 17.8% | ||
| Q1 24 | -22.0% | 8.6% |
| Q4 25 | 4.2% | 10.4% | ||
| Q3 25 | 7.0% | 1.8% | ||
| Q2 25 | 6.1% | 2.2% | ||
| Q1 25 | 11.2% | 2.3% | ||
| Q4 24 | 10.3% | 9.1% | ||
| Q3 24 | 12.4% | 1.7% | ||
| Q2 24 | 13.8% | 2.4% | ||
| Q1 24 | 8.8% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
